- Home
- BRTX vs ADN Comparison
BRTX vs ADN Comparison
Compare BRTX & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- ADN
- Stock Information
- Founded
- BRTX 1997
- ADN 2006
- Country
- BRTX United States
- ADN United States
- Employees
- BRTX N/A
- ADN N/A
- Industry
- BRTX Managed Health Care
- ADN Power Generation
- Sector
- BRTX Health Care
- ADN Utilities
- Exchange
- BRTX Nasdaq
- ADN Nasdaq
- Market Cap
- BRTX 12.5M
- ADN 10.0M
- IPO Year
- BRTX N/A
- ADN N/A
- Fundamental
- Price
- BRTX $1.43
- ADN $3.24
- Analyst Decision
- BRTX
- ADN
- Analyst Count
- BRTX 0
- ADN 0
- Target Price
- BRTX N/A
- ADN N/A
- AVG Volume (30 Days)
- BRTX 102.2K
- ADN 802.6K
- Earning Date
- BRTX 11-11-2025
- ADN 08-12-2025
- Dividend Yield
- BRTX N/A
- ADN N/A
- EPS Growth
- BRTX N/A
- ADN N/A
- EPS
- BRTX N/A
- ADN N/A
- Revenue
- BRTX $605,200.00
- ADN $115,000.00
- Revenue This Year
- BRTX $232.67
- ADN $6,528.51
- Revenue Next Year
- BRTX $52.92
- ADN N/A
- P/E Ratio
- BRTX N/A
- ADN N/A
- Revenue Growth
- BRTX 247.62
- ADN N/A
- 52 Week Low
- BRTX $1.21
- ADN $1.71
- 52 Week High
- BRTX $2.55
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- BRTX 37.54
- ADN 47.83
- Support Level
- BRTX $1.56
- ADN $2.75
- Resistance Level
- BRTX $1.63
- ADN $3.34
- Average True Range (ATR)
- BRTX 0.10
- ADN 0.43
- MACD
- BRTX -0.02
- ADN -0.15
- Stochastic Oscillator
- BRTX 0.00
- ADN 16.12
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space, including liquid hydrogen carriers such as methanol. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.